Skip to main content
Caplight Logo









Yomi Pharma

Yomi Pharma

Private
LimogesHealthcare & Life Scienceshttp://yomipharma.com/

Last Round

Seed

Oct 3, 2025

Est. Valuation

$7.19M

Total Funding Raised

$1.48M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Yomi Pharma is a biotechnology company that develops targeted therapies for resistant lung cancer by exploiting the properties of the sortilin protein.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverypeptide therapeuticspreclinical developmentbiotech startuponcology researchtherapeutic developmentlife sciencesdrug licensingpharma R&Dwet-lab research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Yomi Pharma Comparables

Compare Yomi Pharma with similar companies based on industry and business-model similarity.

Yomi Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Apmonia Therapeutics
77%
Sortina Pharma
77%
PEP-Therapy
70%

Yomi Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 3, 2025
GrantJan 1, 2025

Yomi Pharma Investors

Notable investors and investment history

Yomi Pharma investors
InvestorRounds
Région Nouvelle-AquitaineGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 3, 2025

    $1.38M raised in Seed round.

  • Jan 1, 2025

    $107K grant from Région Nouvelle-Aquitaine

Yomi Pharma Filings

Explore SEC and related filing metadata, where available.

Yomi Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Yomi Pharma's valuation, stock price, and market status.

Is Yomi Pharma a public or private company?

Yomi Pharma is a private company.

What is the current stock price of Yomi Pharma?

Yomi Pharma is a private company with no public stock price. No recent secondary market data is available.

How much is Yomi Pharma worth (valuation)?

Yomi Pharma's valuation is estimated at $7.2M based on funding round data.

Can I buy Yomi Pharma stock?

Yomi Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Yomi Pharma's last funding round?

Yomi Pharma's most recent funding round was Seed on October 3, 2025.

Who are the main investors in Yomi Pharma?

Key investors in Yomi Pharma include Région Nouvelle-Aquitaine.

Will Yomi Pharma IPO soon?

No public IPO plans have been announced for Yomi Pharma.

How can I track Yomi Pharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Yomi Pharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLimoges
Year Founded2023
Last FundingOct 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?